Related Experiment Video
Updated: Dec 26, 2025
Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
Ventilator-associated pneumonia in adults: a narrative review
Laurent Papazian1,2, Michael Klompas3,4, Charles-Edouard Luyt5,6
1Médecine Intensive Réanimation, Hôpital Nord, Hôpitaux de Marseille, Chemin des Bourrely, 13015, Marseille, France. laurent.papazian@ap-hm.fr.
Ventilator-associated pneumonia (VAP) is a common ICU infection linked to longer hospital stays and increased mortality. Early diagnosis, targeted antibiotic therapy, and prevention strategies are crucial for managing VAP.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Pulmonology
Background:
- Ventilator-associated pneumonia (VAP) is a frequent intensive care unit (ICU)-acquired infection.
- VAP incidence ranges from 5% to 40%, associated with prolonged mechanical ventilation and ICU stays.
- Attributable mortality for VAP is approximately 10%, particularly in surgical ICU patients.
Purpose of the Study:
- To review the current understanding and management of VAP.
- To highlight the importance of microbiological confirmation in VAP diagnosis.
- To discuss emerging diagnostic tools and prevention strategies for VAP.
Main Methods:
- Literature review of VAP epidemiology, diagnosis, and management.
- Discussion of current diagnostic controversies, including sampling methods.
- Analysis of VAP prevention strategies and treatment guidelines.
Main Results:
- VAP significantly increases mechanical ventilation duration and ICU length of stay.
- Microbiological confirmation is strongly recommended, though sampling methods remain debated.
- Emerging diagnostic technologies are expected to influence future VAP management.
- Prevention focuses on minimizing mechanical ventilation and promoting early liberation.
- A 7-day antibiotic course is generally recommended, with de-escalation based on susceptibility results.
Conclusions:
- VAP is a significant cause of morbidity and mortality in ICUs.
- Optimizing diagnosis through microbiological confirmation and employing effective prevention strategies are key.
- Future advancements in diagnostics and a focus on evidence-based treatment durations are essential for improving patient outcomes.
More Related Videos
05:51Author Spotlight: Unraveling the Impact of Mechanical Ventilation on Diaphragm Function and Patient Outcomes
Published on: November 3, 2023
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Related Concept Videos
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:30Pneumonia III: Complications and Assessment
01:23Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
01:29Pneumonia II: Pathophysiology
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: